Search Ontology:
ChEBI
ximelagatran
- Term ID
- CHEBI:65172
- Synonyms
-
- ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(N'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate
- ethyl N-{(1R)-1-cyclohexyl-2-[(2S)-2-{[4-(N'-hydroxycarbamimidoyl)benzyl]carbamoyl}azetidin-1-yl]-2-oxoethyl}glycinate
- Exanta
- Exarta
- H 376-95
- H 376/95
- H 37695
- ximelagatran
- ximelagatran (oxime form)
- ximelagatranum
- Definition
- A member of the class of azetidines that is melagatran in which the carboxylic acid group has been converted to the corresponding ethyl ester and in which the amidine group has been converted into the corresponding amidoxime. A prodrug for melagatran, ximelagatran was the first orally available direct thrombin inhibitor to be brought to market as an anticoagulant, but was withdrawn in 2006 following reports of it causing liver damage.
- References
-
- CAS:192939-46-1
- DrugBank:DB04898
- Drug_Central:2852
- KEGG:D01981
- PMID:12846595
- PMID:15487959
- PMID:16084146
- PMID:16106594
- PMID:16123912
- PMID:16511607
- PMID:16767816
- PMID:17319469
- PMID:17636192
- PMID:19028773
- PMID:20020269
- PMID:28338626
- Reaxys:14559655
- Wikipedia:Ximelagatran
- Ontology
- ChEBI ( EBI )
- is a type of
- has_functional_parent
-
- has_role
-
- inverse is_tautomer_of
-
- is_tautomer_of
-
Phenotype
Phenotype resulting from ximelagatran
Phenotype where environments contain ximelagatran
Phenotype modified by environments containing ximelagatran
Human Disease Model